Aurobindo Pharma USA - About the company
Aurobindo Pharma USA is an unfunded company based in East Windsor (United States), founded in 1994. It operates as a Distributor of generic drugs. Aurobindo Pharma USA has not raised any funding yet. The company has 60 active competitors, including 3 funded and 10 that have exited. Its top competitors include companies like Pfizer, Cost Plus Drug and Lovell Government Services.
Company Details
- Website
- www.aurobindousa.com/
- Phone Number
- +1 **********
- Registered Address
- East Windsor, New Jersey
Key Metrics
Founded Year
1994
Location
East Windsor, United States
Stage
Unfunded
Ranked
6th among 60 active competitors
Employee Count
1,208 as on Jun 30, 2026
Legal entities associated with Aurobindo Pharma USA
Aurobindo Pharma USA is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
AUROBINDO PHARMA U.S.A., INC. CIN: 200962874 , United States, Active | - | 457 (As on Dec 31, 2024) | - |
Sign up to download Aurobindo Pharma USA's company profile
Aurobindo Pharma USA's funding and investors
Aurobindo Pharma USA has not raised any funding rounds yet.
Aurobindo Pharma USA's founders and board of directors
Founder? Claim ProfileAurobindo Pharma USA's employee count trend
Aurobindo Pharma USA has 1,208 employees as of Jun 26. Here is Aurobindo Pharma USA's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Aurobindo Pharma USA's Competitors and alternates
Top competitors of Aurobindo Pharma USA include Pfizer, Cost Plus Drug and Lovell Government Services. Here is the list of Top 10 competitors of Aurobindo Pharma USA, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Pfizer 1849, New York City (United States), Public | Provider of pharmaceutical products for multiple disease treatments | - | 68/100 | |
2nd | Cost Plus Drug 2016, Dallas (United States), Unfunded | Distributor of generic drugs | - | - | 45/100 |
3rd | Lovell Government Services 2013, Pensacola (United States), Unfunded | Distributor of pharmaceutical products | - | - | 43/100 |
4th | YARAL Pharma 2021, Parsippany (United States), Unfunded | Provider of authorized generic and complex generic medicines to enhance healthcare | - | - | 32/100 |
5th | Auburn 1993, Rochester Hills (United States), Unfunded | Wholesaler distributes generic drugs purchased directly from manufacturers to pharmacies | - | - | 28/100 |
6th | Aurobindo Pharma USA 1994, East Windsor (United States), Unfunded | Distributor of generic drugs | - | - | 38/100 |
7th | KeySource 1996, Cincinnati (United States), Acquired | Distributor of pharmaceutical products | - | 26/100 | |
8th | Red Oak Sourcing 2014, Foxborough (United States), Seed | Distributor of generic drugs | $2.1M | - | 26/100 |
9th | Bayshore Pharmaceuticals 2011, Short Hills (United States), Acquired | Manufacturer of pharmaceutical products | - | - | 25/100 |
10th | Turnkey Pharmacy Solutions 2012, Salt Lake City (United States), Acquired | Pharmaceutical distributors | - | - | 25/100 |
Looking for more details on Aurobindo Pharma USA's competitors? Click here to see the top ones
Aurobindo Pharma USA's Investments and acquisitions
Aurobindo Pharma USA has made no investments or acquisitions yet.
Reports related to Aurobindo Pharma USA
Here is the latest report on Aurobindo Pharma USA's sector:
News related to Aurobindo Pharma USA
Media has covered Aurobindo Pharma USA for a total of 2 events in the last 1 year.
•
Aurobindo Pharma gets FTC nod for $250 million Lannett buyoutMoneycontrol•Jun 22, 2026•Lannett, Aurobindo Pharma, Aurobindo Pharma USA
•
Aurobindo Pharma recalls pain relief drug in US due to manufacturing issuesIndiatimes•Jun 27, 2025•Aurobindo Pharma USA
•
•
New Mountain Capital to Acquire Natrol from Aurobindo PharmaBusiness Wire•Oct 25, 2020•New Mountain Capital, Aurobindo Pharma, Jarrow Formulas, Natrol and 4 others
•
•
•
Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Consumer Level Recall of 38 Lots of Ranitidine Tablets 150mg, Ranitidine Capsules 150mg, Ranitidine Capsules 300mg and Ranitidine Syrup 15mg/mL Due to the Detection of NDMA (Nitrosodimethylamine) ImpurityCMOCRO•Nov 06, 2019•Aurobindo Pharma USA
•
•
•
Aurobindo Pharma USA recalls 80 lots of blood pressure drug from AmericaIndiatimes•Jan 01, 2019•Aurobindo Pharma USA
Are you a Founder ?
FAQs about Aurobindo Pharma USA
Explore our recently published companies
- Danieli Corus - India based, 2001 founded, Unfunded company
- Satyesh Brinechem - Kutch based, 1923 founded, Unfunded company
- Solaris ChemTech - Gurugram based, 2000 founded, Acquired company
- Pinus-Buchhaltungssoftware - Switzerland based, Unfunded company
- Unilever Professional - Mumbai based, 2021 founded, Unfunded company
- Cresus - Switzerland based, Unfunded company